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ABSTRACT Previous studies havedemonstrated a calcium-dependent interaction of calmodulin (CaM) andFas that is regulated
duringFas-inducedapoptosis in several cell lines, including cholangiocarcinoma, Jurkat cells, andosteoclasts. ThebindingofCaM
and Fas has been identiﬁed on residues 231–254 of Fas; the V254N point mutation decreases the CaM/Fas binding, and the
C-terminal deletion mutation increases the CaM/Fas binding. Recent studies have shown that CaM is recruited into the Fas-
mediated death-inducing signaling complex (DISC) in a calcium-dependent manner. However, the molecular mechanisms
whereby Fas mutations and CaM/Fas binding might regulate Fas-mediated DISC formation are unknown. In this study we
investigated the binding thermodynamics and conformation of the CaM/Fas complexes with combined explicit solvent molecular-
dynamics simulations and implicit solvent binding free-energy calculations. The binding free-energy analysis demonstrated that
theFasV254Npointmutation reduced its bindingafﬁnitywithCaM. In contrast, theFasmutantwith thedeletion of the15aminoacid
at theC-terminus increased its binding toCaM. Theseobservations are consistentwith previous ﬁndings frombiochemical studies.
Conformational analyses further showed that the Fas V254N mutation resulted in an unstable conformation, whereas the
C-terminal deletion mutation stabilized the Fas conformation, and both mutations resulted in changes of the degree of correlation
between the motions of the residues in Fas. Analysis of the CaM/Fas complex revealed that CaM/Fas binding stabilized the
conformation of both CaM and Fas and changed the degree of correlated motion of the residues of CaM and Fas. The results
presented here provide structural evidence for the roles of Fas mutations and CaM/Fas binding in Fas-induced DISC formation.
Understanding themolecular mechanisms of CaM/Fas binding in Fas-mediated DISC formation should provide important insights
into the function of Fas mutations and CaM in regulating Fas-mediated apoptosis.
INTRODUCTION
Fas death receptor-activated signaling pathways have been
shown to regulate apoptosis in a variety of cells, including
cholangiocarcinoma, Jurkat cells, and osteoclasts (1,2).
Dysfunction of Fas and its signaling pathways has been as-
sociated with diseases in both mice and humans (3–6). Mu-
tations of Fas expression and its signaling in humans are
associated with autoimmune lymphoproliferative syndrome
(ALPS) (3,4,6), a heritable disorder of lymphocyte homeo-
stasis. It has been reported that MRL/lpr/ mice that are
homozygous for Fas mutations develop anALPS-like disease
(5). This is in accordwith the observation that numerous types
of cancer express mutations of Fas that impair its function (7–
12). In human cholangiocarcinoma, down-regulation of Fas is
correlated with increased tumor size and a decreased survival
time for patients (12–14). Thus, understanding the molecular
mechanisms that are responsible for regulating the Fas sig-
naling pathway is potentially important for identifying novel
strategies and targets for the treatment of these diseases.
The Fas-activated signaling pathway is well characterized.
Fas is a six-a-helix structure with a single hydrophobic site
located within helices 5 and 6 (15). The Fas death receptor has
the ability to self-associate or bind with other target proteins,
including calmodulin (CaM) and the Fas-associated death
domain (FADD) (15,16). Upon activation by its ligand, Fas
recruits FADD via its death domain (DD), which in turn re-
cruits the downstream signaling molecule caspase-8, or its
enzymatic inactive homolog FLICE-like inhibitory protein
(FLIP), to form the death-inducing signaling complex (DISC).
The formation of the DISC is a crucial step in Fas-mediated
signaling. It has been demonstrated that helices 1–2 of Fas
associate with CaM (1,2) and that this interaction is regulated
during Fas-mediated apoptosis. CaM regulates a variety of
cellular Ca21-dependent processes. The structure of CaM
consists of eight helices that form four calcium-binding loops,
which exhibit the characteristic EF hand structure (17). The
dumbbell-shaped structure of CaM is composed of two
globular terminal regions and two helices comprising the in-
terdomain region (18). Upon binding of the calcium ions, the
helices at either end of the EF hand rearrange and cause the
protein to take on an open conformation, allowing for a
greater interaction with target proteins such as Fas (17,19).
Recently, CaM was found to be recruited into the Fas-medi-
ated DISC (20); however, the role of CaM/Fas binding in the
formation of the Fas-mediated DISC is unknown. It has been
postulated that the interaction of Fas with CaM alters the
conformation of Fas and therefore affects the binding afﬁnity
between Fas and FADD (19). The valine254 to asparagine
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(V254N) mutation of Fas, which results in a deﬁciency of Fas
function and Fas-mediated signaling (15), has been shown to
decrease the binding of Fas to both CaM and FADD (1,15).
Furthermore, a C-terminal mutation, a deletion of the last 15
residues of the C-terminal of Fas, enhances the binding of Fas
to CaM (19) and FADD (21). These mutant forms of Fas may
result in conformational changes of Fas, thus altering its
ability to interact with CaM and FADD. Further investigation
is warranted to determine the molecular mechanisms under-
lyingCaM/Fas binding and its role in regulating Fas-mediated
signaling pathways.
In this study we investigated the conformation and binding
thermodynamics of the CaM/Fas complex using explicit sol-
ventmolecular dynamics (MD) simulations and implicit solvent
binding free-energy calculations. Binding free-energy cal-
culations showed decreased binding between the Fas V254N
mutant and CaM, but increased binding between the Fas
C-terminal deletion mutant and CaM. These observations are
consistent with previous studies that analyzed puriﬁed re-
combinant proteins by means of protein pull-down assays
(19). Conformational analyses showed that the Fas V254N
mutation resulted in an unstable conformation, whereas the
C-terminus deletion mutation stabilized the Fas structure.
Bothmutations altered the degree of correlation seen between
the motions of the residues in Fas. Analysis of the CaM/Fas
complex revealed conformation changes and stabilization of
both the CaM and Fas proteins, as well as changes in the
degree of correlated motion of the residues of the proteins
upon the formation of the CaM/Fas complex. Results from
this study provide structural evidence in support of the im-
portant role of CaM/Fas binding in Fas-induced DISC for-
mation. Understanding themolecularmechanism of CaM/Fas
binding in Fas-mediated DISC formation should provide
important insights into the function of CaM in regulating Fas-
activated signaling pathways.
MATERIALS AND METHODS
Protein complex construction
The initial protein structures of the Fas DD (1ddf) (15) and Ca21-bound CaM
(3cln) (22), which were used for theMD simulations, were obtained from the
Protein Data Bank. All mutations in this study were performed with the
mutagenesis function of PyMol (23), and the visualizations used in the study
were created with Visual Molecular Dynamics (VMD) software (24).
The initial CaM/Fas complex was determined using the docking utilities
ZDOCK and RDOCK (25–27). The developers of these programs participate
regularly in the Critical Assessment of Prediction of Interactions (CAPRI)
Challenge (28–30). This challenge provides developers of protein docking
algorithms an opportunity to compare their experimental complexes with
known structures. These programs have consistently performed well in such
exercises, and during the most recent event, the group predicted ﬁve out of
six targets within the acceptable threshold; the one unsuccessful target was
limited by inaccurate homologymodels (30). Additionally, published studies
have successfully used these docking programs to generate complexes to be
subjected to MD simulations and obtain satisfactory research results (31,32).
Previous biochemical studies (19) and predictions using the CaM Target
Database (17) have determined that the CaM binding region is located within
helices 1 and 2 (residues (res) 231–254) of the Fas DD. This region exhibits
the common 1-5-10 CaM binding motif (19). With the known binding site
used as a docking constraint, the ZDOCK docking software was used to
generate 2000 possible complexes that were scored based on their geometry,
desolvation, and electrostatics (25). The RDOCK program used CHARMM
tominimize the structures and determine the electrostatic, van derWaals, and
contact energies associatedwith each of the proposed complexes (26). On the
basis of these results, the 2000 predicted structures were ranked, and the
highest-ranking structure was chosen to be the most probable protein com-
plex. The structures generated for the CaM and Fas complexes, from CaM,
Fas, and Fas mutants are shown in Fig. 1.
MD simulation
To elucidate the molecular mechanisms underlying CaM and Fas interac-
tions, a total of seven MD simulations were performed using the AMBER 9
package (33) (Table 1). The ‘‘parm99’’ parameters of the AMBER force ﬁeld
were assigned to the atoms in the simulated system, and a standard MD
simulation protocol was conducted for the seven systems. The protein, or
protein complex, was ﬁrst minimized and then solvated in a TIP3P (34) water
box with a 150 mM NaCl physiological salt concentration. A buffer of 10 A˚
was set between the protein and the box boundaries to reduce potential ar-
tifacts arising from periodicity. Additional ions were added to each system to
neutralize the charge of the protein or protein complex. The AMBER 9
program Leap was used to solvate and neutralize the system. The solvent was
then minimized and equilibrated for 10 ps while the proteins and ions were
constrained. The entire system was then heated up to 300K by steps of 50K,
lasting 10 ps each, at a constant temperature and volume, and 30 ns simu-
lations at 300K constant temperature and 1 atm constant pressure were
conducted for each system. The ﬁrst 15 ns of each simulation served as the
equilibration of the system, and the last 15 ns simulations served as the
production run for data analysis. Periodic boundary conditions were applied
to the simulated systems. The SHAKE constraints were applied to all hy-
drogen-heavy bonds to permit a dynamics time step of 2 fs. Electrostatic
interactions were calculated with the particle-mesh Ewald method (PME)
(35). Both the direct space PME and Lennard-Jones cutoffs were set at 10 A˚.
The data for the MD simulations were collected every 2 ps. The simulations
were performed on a local BlueGene cluster using 32 processors for each
simulation.
Binding free-energy calculations
To verify the equilibration of the protein complex obtained using the docking
programs, and to better understand the effects of protein mutations and
conformational changes on the binding afﬁnity, binding free energies were
calculated for the three CaM/Fas complexes in this study. The binding free
energy was calculated with the molecular mechanics-Poisson Bolzmann
surface area (MM-PBSA)method as described in previous studies (18,36,37),
TABLE 1 Seven systems simulated in this study
System
Calmodulin
(CaM)
Fas death
domain (Fas DD)
CaM/Fas
complex
1 Wild-type
(WT)
2 WT
3 V254N mutant
4 C-terminal deletion
mutant
5 CaM WT – Fas WT
6 CaM WT – Fas V254N
mutant
7 CaM WT – Fas C-terminal
deletion mutant
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which was implemented using the AMBER 9 molecular dynamics software
package. TheMM-PBSAmethodcombinesmolecularmechanics, continuum
electrostatics, solvent-accessible surface area calculations, and normal mode
analyses for entropy to calculate the binding free energy from a series of
snapshots obtained from the trajectories of the MD simulations.
As stated in Eq. 1, the change of any energy component of a system can be
determined from the various components of the complex:
DG ¼ Gcomplex  Gprotein  Gligand; (1)
where G is the average value over the production trajectory.
The binding energy is the sum of the molecular mechanics contribution to
the energy (also known as the gas phase energy) and the solvation free energy
of the system (Eq. 2):
DGbinding ¼ DGMM1DGsolv (2)
DGsolv ¼ DGpolar1DGnonpolar: (3)
The solvation free energy ismade up of both polar and nonpolar contributions
(Eq. 3). The polar contribution to the solvation free energy is based on the
electrostatics of the system and calculated using the Poisson-Boltzman
equation. In AMBER, this term is computed with the pbsa solver. The
nonpolar component is dependent on the surface area of the molecule that is
accessible to the solvent.
The gas phase contribution to the binding free energy is equal to the dif-
ference between the molecular mechanics energy and the entropy of the
system (Eq. 4). The molecular mechanics portion of the binding energy cal-
culation (Eq. 5) is equal to the sum of the van der Waals energy, electrostatic
energy, and internal energy resulting from bond, angle, and torsion energies.
T represents the temperature and S is the entropy of the system. The entropy of
the system was computed using normal mode analysis. All structures were
completely energy-minimized before analysis using the nmode program of
AMBER.
DGMM ¼ DEMM  TDS (4)
DEMM ¼ DEvdw1DEelec1DEint: (5)
The AMBER program mm_pbsa was used to determine the binding free
energy for the complexes. Snapshots with a 10 ps time step from the MD
production trajectories were used for the binding free-energy calculations.
The binding free energy was calculated by ﬁnding the energy difference
between the complex and the receptor and ligand (Eq. 1). The complex for
each of the frames in the production trajectory was decomposed into receptor
and ligand components. The resulting three components (complex, receptor,
and ligand) were then used for the binding free-energy analysis. For the
determination of polar solvation energy with the Poisson-Boltzman equation,
values of 1 and 78.4 (18) were used for the dielectrics of the solute and
solvent, respectively. Also, an ionic strength of 150 mM and a temperature of
300K were deﬁned based on the conditions for the MD simulations along
with a scale of two grids per A˚. Due to the computational cost of calculating
the entropy term, a subset of 1154 frames from the 30 ns production tra-
jectories was used for normal mode analysis to obtain the entropy of the
system. On the basis of the mean and standard deviation (SD) from the
binding free-energy calculations, a Student’s t-test with 95% conﬁdence was
conducted to determine whether the effect of Fas mutations on the binding
afﬁnity between CaM and Fas was statistically signiﬁcant.
Conformation analyses
For this study a series of analyses were carried out to better understand the
conformational character of CaM and the various Fas mutants, and the
conformational changes induced by their interaction. The root mean-square
deviation (RMSD) of protein backbone atoms was analyzed in conjunction
with the binding free energy results to determine the systems’ equilibration
tendencies and its convergence. Root mean-square ﬂuctuations (RMSFs) of
the proteins were calculated on a residue-by-residue basis and averaged over
the production simulation trajectories to observe the conformation ﬂuctua-
tion of protein domains. Dynamical cross-correlation maps (normalized
covariance matrices) between residues provided insight into which residues
FIGURE 1 Constructed complexes of CaM and Fas. (A)
Complex of WT CaM and Fas. (B) Complex of CaM and
Fas V254N mutant. (C) Complex of CaM and Fas C-ter-
minal mutant.
Binding and Structure of CaM/Fas Complex 5915
Biophysical Journal 95(12) 5913–5921
have general movements correlating to the motion of other residues, and the
degree of this correlation. These analyses were performed using the ptraj
program of AMBER, and MATLAB (The MathWorks, Natick, MA) was
used to generate the cross-correlation plots.
Statistical methods
To determine the effect of Fas mutations on binding afﬁnity, the average
values and the SDs of the binding free energy were calculated for the three
CaM/Fas complexes. Because the adjacent snapshots inMD trajectories have
a tendency to be correlated with each other, the autocorrelation times (38–40)
for the binding free energy and the components of the binding free energy
were obtained and the trajectories were resampled into statistically inde-
pendent periods to calculate the statistical SD. The autocorrelation time twas
calculated as in previous studies (39,40). To avoid the potential issue that the
individual quantity could have a different autocorrelation time and could
couple to the longest-time-scale system property, we chose to calculate the
autocorrelation time t for the system RMSD as a whole (40). The longest
decorrelation times of 2t based on the RMSD of the three CaM/Fas com-
plexes were chosen as the decorrelation times to calculate the SDs of the
binding free energy and its components (40). With the obtained decorrelation
times, bootstrap analyses (41) were performed with the use of a protocol
similar to that of Chen and Pappu (42): 1), the ﬁrst set of frames of the
trajectory within 2t time was not used for the analyses; 2), a random frame
after 2t time was chosen as the starting point and new resampled data sets
within the 2t time period were generated; and 3), steps 1 and 2 were repeated
1000 times. Each subsample data set that was obtained was used to calculate
the averages of the subsamples, and the averages over all the subsamples
were used to calculate the SD of the studied variables. With the mean and
SDs of the binding free energy for the three CaM/Fas complexes, Student’s
t-test (44), with 95% conﬁdence, was used to determine whether the effect of
Fas mutations on the binding afﬁnity of the CaM/Fas complex was signiﬁ-
cant.
FIGURE 2 Binding free energy of the complexes of CaM and Fas over the
30 ns MD simulations. (A) Binding free energy without the entropy
component over time. (B) The entropy component of binding free energy
over time. Because of the computational cost to calculate the entropy term,
the number of sampling points for the entropy calculation was different from
that for the calculations of other components of binding free energy; thus, the
entropy term and other components of the binding free energy are shown in
two ﬁgures.
FIGURE 3 RMSD for the Fas DD protein core (res 225–318) and CaM in
its WT and in the CaM/Fas complex over the 30 ns MD simulation for
different simulation cases: (A) the Fas DD protein core, (B) the N-terminal of
CaM (res 1–77), and (C) the C-terminal of CaM (res 78–148).
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RESULTS AND DISCUSSION
The binding free energy of the complexes over the 30 ns MD
simulations, which was calculated as the ensemble-averaged
value over the production trajectory, showed that the energy
of the systems converged after the ﬁrst 15 ns of the produc-
tion simulation (Fig. 2). The RMSD of CaM (for both the
N- and C-termini) and the Fas DD protein core (res 225–318)
from the CaM/Fas complex (Fig. 3) over the 30 ns MD
simulations also showed that the systems reached initial
equilibration after the ﬁrst 15 ns. It is important to note that
although large RMSD values (14 A˚) are observed for the Fas
protein core from the Fas/CaM complex, the same degree of
RMSD was also observed in the individual Fas protein (Fig.
3 A). This is indicative not of protein complex rearrangement,
but rather the natural ﬂexibility of the core of the Fas protein.
The remaining 15 ns were then used for the analyses of Fas
and CaM conformational changes and binding thermody-
namics.
Previous biochemical studies showed that the V254N
mutation of Fas decreases the ability of Fas to bind with CaM
(19), and a C-terminal mutation, a deletion of the last 15
residues of the C-terminus of Fas, enhances the binding of
CaM and Fas (19). Using the MD simulation trajectories, we
performed binding free-energy calculations and compared
the results with those from experimental observations. After
validating our binding afﬁnity results with the experimental
observations, we investigated the conformation changes of
Fas induced by its mutations, as well as the structural changes
of Fas and CaM that resulted from the formation of the CaM/
Fas complex.
Binding thermodynamics
To determine the effect of the Fas V254N and C-terminal
deletion mutations on the ability of Fas to bind with CaM,
binding free-energy calculations were performed on the Fas/
CaM complexes that consisted of CaM bound to three dif-
ferent Fas variations. All of the resulting energy calculations,
including the values averaged over the 15–30 ns trajectories
and the SDs obtained by statistical analyses, are shown in
Table 2.
The calculated relative binding free energies of the CaM/
Fas mutants with respect to the wild-type (WT) CaM/Fas
complex revealed a binding free-energy increase of 10.07
kcal/mol by the Fas V254N mutation and a binding free-
energy decrease of 20.59 kcal/mol by the deletion of the 15
C-terminal amino acids of the Fas DD (Table 2). The relative
binding free-energy analyses showed that the deletion of the
15 C-terminal amino acids of the Fas DD had a signiﬁcant
positive effect on the binding afﬁnity of the CaM/Fas com-
plex, whereas the V254N point mutation signiﬁcantly re-
duced the binding afﬁnity for the complex.
The calculated results were consistent with the binding
afﬁnity trends observed in previous biochemical binding
studies (19). By analyzing the energy components, one can
see where the majority of the energy contributions originate.
The van der Waals energy for the ﬁrst two cases is relatively
constant, whereas the value for the C-terminal mutation is
two times less than this value. This is to be expected because
the ﬁrst two complexes differ by a single point mutation and
the latter is lacking a total of 15 residues. Fas mutations also
resulted in signiﬁcantly different electrostatic potential en-
ergy and polar solvation energy components for CaM/Fas
mutant complexes compared to the WT CaM/Fas complex.
Conformational changes of Fas by its mutations could con-
tribute to the changes seen in each energy component of the
binding free energy, and thus could have an effect on the
binding afﬁnity of the complex.
After validating our binding free-energy analysis results by
comparisonwith those obtained fromexperimental studies,we
further investigated the conformation changes of Fas induced
by its mutations, as well as the structural changes of Fas and
CaM resulting from the formation of the CaM/Fas complex.
TABLE 2 Free energy calculations for the binding of CaM to Fas
Energy Fas WT
Fas V254N
mutant
Fas C-terminal
deletion mutant
DEvdw 43.38 6 4.23 46.26 6 2.93 95.97 6 2.19
DEelec 484.78 6 53.51 604.05 6 22.15 810.77 6 27.22
DGpolar 476.94 6 49.87 609.65 6 23.54 835.65 6 30.48
DGnonpolar 8.39 6 0.64 9.32 6 0.27 15.59 6 0.34
TDS 52.50 6 2.94 49.65 6 1.92 56.81 6 4.04
DGbinding 7.11 6 4.67 0.33 6 4.73 29.87 6 3.41
DDGbinding 6.78* 22.74*
Results from biochemical
binding studies (19)
Strong Weaker compared to the WT Stronger compared to the WT
All values in this table are expressed in terms of kcal/mol. DEvdw is the van der Waals energy, DEelec is the electrostatic energy, DGpolar is the polar
contribution based on the solution to the Poisson-Boltzmann equation, DGnonpolar is the nonpolar contribution to the binding energy based on molecular
surface area, TDS is the solute entropic contribution, DGbinding is the overall binding free energy for the complex, and DDGbinding is relative binding free
energies with respect to the WT CaM/Fas complex.
*Differences that are statistically signiﬁcant (Student’s t-test, p , 0.05).
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Conformational changes in Fas
Previous experiments have demonstrated that the V254N
mutation of Fas decreases Fas binding to CaM (19), and a
deletion of the last 15 residues of the C-terminus of Fas en-
hances the binding of Fas to both CaM (19) and FADD (21).
However, the molecular mechanism underlying CaM and Fas
binding, and how the mutations contribute to the binding of
Fas to CaM are unknown. RMSF comparisons of Fas (Fig. 4)
and dynamical cross-correlation maps for the comparison of
correlated motion of residues in Fas (Fig. 5) for different
conditions showed that Fas conformations were changed by
its mutations and by its binding with CaM.
For Fas in its WT state, V254N mutation, and C-terminal
deletion mutation, the RMSF (Fig. 4, A and B) showed that
the V254N mutation caused large conformation ﬂuctuations
on or near its binding site with CaM (res 231–270), and the
C-terminal deletion mutation resulted in an overall lesser
degree of conformational ﬂuctuation. These were observed in
both single Fas (Fig. 4 A) and the Fas/CaM complex (Fig.
4 B). Upon binding with CaM, Fas experienced an overall
lesser degree of conformational ﬂuctuation compared to that
of the single Fas. Dynamical cross-correlation maps that were
used to investigate the correlation between the motion of the
residues in the protein provided further insight into the effect
of Fas mutations and Fas binding with CaM (Fig. 5). The top
left halves of Fig. 5, A–C, are the cross-correlation maps for
the Fas WT, V254N mutation, and C-terminal mutation. The
results show that the Fas V254N mutation increased the de-
gree of correlated motion (white) between res 271–332 and
res 221–241 compared to that of the Fas WT. The C-terminal
deletion mutation resulted in an overall lesser degree of both
correlated (white) and anticorrelated (black) movement for
the residues of Fas compared to the WT case. These results
indicate that the Fas mutations directly affected the degree of
correlated motion within the residues of Fas. Taken together,
the conformational changes of Fas and the changes in the
degree of correlated motion of the protein as a result of the
V254N and C-terminal mutations show that these Fas mu-
tations may contribute to the binding of Fas with CaM ob-
served in previous experiments (19).
Fig. 5 A is the cross-correlation map for Fas in its WT state
(top left) and after binding with CaM (bottom right). It shows
that the degree of both correlated (white) and anticorrelated
movement (black) in Fas is reduced by binding with CaM,
especially the Fas N-terminal and C-terminal regions (cir-
cled). Fig. 5 B is the cross-correlation map for the Fas V254N
mutant (top left) and after formation of the CaM/Fas complex
(bottom right). It shows an increased degree of correlation
(white) between the movements of res 271–332 and res 221–
241, and an increased degree of anticorrelation (black) be-
tween the movements of res 235–265 and res 221–241. Fig.
5C is the cross-correlation map for the Fas C-terminal mutant
(top left) and after Fas binding with CaM (bottom right). It
shows that an overall decreased degree of both correlated and
anticorrelated movement for the residues in Fas resulted from
binding with CaM.
In summary, Fas conformational ﬂuctuations and the de-
gree of correlation seen between the motions of the residues
in Fas induced by the Fas mutations provide structural evi-
dence to support previous experimental observations that the
Fas V254N mutation decreases the ability of Fas to bind with
CaM, and the Fas C-terminal deletion mutation enhances the
FIGURE 4 (A) RMSF comparison of the Fas DD in its WT, V254N
mutation, and C-terminal deletion mutation. (B) RMSF comparison of the
Fas DD after Fas binding to CaM with Fas in its WT, V254N mutation, and
C-terminal deletion mutation. (C) RMSF comparison of Fas DD and the Fas
DD after its binding to CaM.
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binding of Fas to CaM (19). The changes in conformation
and degrees of correlation provide structural insight into the
effect of the formation of the CaM/Fas complex on the
structure of Fas, and the ability of Fas to bind with FADD to
form the DISC (21).
Conformational changes in CaM
The association that occurred between the WT Fas DD and
CaM affected not only the conformation of Fas and correla-
tion of the residues of Fas, as described above, but also the
conformation of CaM and the degree of correlated motion of
the residues in CaM (Fig. 6, A and B). With the calculation of
RMSF values for each of the residues of CaM in both the WT
and complex states (Fig. 6 A), the formation of the CaM/Fas
complex was shown to have a stabilizing effect on the resi-
dues of CaM. During the control run of CaM, in the absence
of complex formation with Fas, the residue ﬂuctuations
varied greatly and exhibited peaks at residues in the follow-
ing regions: the four calcium-binding loops circled by the
dashed line in Fig. 6 A (res 20–28, 56–64, 93–101, and 129–
137), and the two linker regions circled by the solid line in
Fig. 6 A (res 39–44 and 112–117) connecting the two EF
hands in each of the globular regions (44). These six domains
that exhibited the greatest movement were the nonhelical
components of CaM. Upon formation of the complex with
the Fas WT, the overall structure of CaM was stabilized and
many of these nonhelical components experienced a lesser
degree of ﬂuctuation. The cross-correlation maps (Fig. 6 B)
show that the control simulations of CaM exhibit a high
degree of correlation (white) between the ﬁrst and second
loops (res 20–28 and 56–64) and between the third and fourth
loops (res 93–101 and 129–137; top left half of Fig. 6 B), and
showed a high degree of anticorrelation (black) between the
two globular domains at the N- and C-terminals (res 20–64
and 93–137). The degree of these correlations and anti-
correlations was seen to lessen upon formation of the Fas/
CaM complex (bottom right half of Fig. 6 B). The confor-
mational change of CaM and the changes of the degree of
correlated motion of residues in CaM, caused by the inter-
action with Fas, may explain the increased interaction of
CaM with other proteins (such as the FLICE-like inhibitory
protein (FLIP)) after association with Fas (45).
The formation of the CaM/Fas complex and Fas mutations
not only caused Fas to experience different conformations
and different degrees of correlated motion, as described
above, it also caused CaM to undergo a stabilizing confor-
mation change and changes in the degree of correlated mo-
tion of the residues of CaM (Fig. 6). The effect of Fas
mutations on the conformation of CaM and Fas was also
FIGURE 5 Dynamical cross-correlation maps to compare the degree of
correlated motion of the residues in the Fas DD (white: correlation between
residues; black: anticorrelation between residues). (A) WT Fas DD (top left)
compared to the Fas DD after its binding with CaM (bottom right) (circled
regions show the correlated motion between Fas N-terminal and C-termi-
nal). (B) Fas DD V254N mutant (top left) compared to the Fas DD V254N
mutant after its binding with CaM (bottom right) (circled regions showed the
correlated motion between res 271–332 and res 221–241, and between res
235–265 and res 221–241). (C) Fas DD C-terminal mutant (top left)
compared to the Fas DD C-terminal mutant after its binding with CaM
(bottom right).
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visible in the entropy values obtained for the CaM/Fas
complexes (Fig. 2 B).
CONCLUSIONS
Taken together, these data demonstrate that the binding of
CaM to Fas results in conformational changes of both CaM
and Fas that stabilize their structure, and affects the degree of
correlated motion of the residues in both CaM and Fas. The
Fas C-terminal deletion mutation stabilized the structure of
Fas, resulted in an overall lesser degree of both correlated and
anticorrelated movement, and increased the CaM/Fas bind-
ing afﬁnity. In contrast, the Fas V254Nmutation destabilized
the structure of Fas, resulted in changes in the degree of
correlated motion of residues, and decreased CaM/Fas bind-
ing afﬁnity. These results provide important molecular evi-
dence for the structural consequences of the binding of Fas
and CaM, and the effects on Fas resulting from its mutations.
Also, these results will facilitate further understanding of the
function of Fas mutations and CaM/Fas binding in the reg-
ulation of Fas-induced DISC formation and Fas-mediated
signaling pathways. These studies should provide important
insights into the identiﬁcation of strategies and targets to treat
diseases characterized by defective Fas signaling, such as
autoimmune diseases, osteoporosis, and cancer.
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